Webinars

The May 2023 NVHR Grassroots Advocacy Call celebrated Hepatitis Testing Day by hearing from clinics and community-based organizations around the country who are leading innovative field and street-based viral hepatitis testing.

The National Viral Hepatitis Roundtable and Hepatitis B Foundation hosted the first-ever Quarterly Hepatitis Roundtable on March 16, 2023. This quarter, we hosted White House advisors Francis Collins and Rachael Fleurence to discuss a national hepatitis C elimination program.

Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs. In response to advocacy and litigation, many states have reduced or eliminated their restrictions, but significant barriers remain in a majority of jurisdictions. This webinar presents our latest snapshot of the national HCV treatment landscape and our team's insights into the road that lies ahead.

During our January 2023 grassroots advocacy call we sat down with Nick Florko from STAT to discuss his investigation titled "Death Sentence" about the failure of state prisons to provide hepatitis C treatment. Read about the investigation here: https://www.statnews.com/death-sentence/

This webinar discusses clinical trial experience as it relates to access and equity. This webinar is part TWO of a two-part series intended for patients, advocates, and other stakeholders who are interested in learning more about the clinical trial process for HBV and HDV. The webinar is co-hosted by the Hepatitis B Foundation and the National Viral Hepatitis Roundtable (NVHR).

This webinar provides an overview of the clinical trial process, current HBV and HDV therapies, and an introduction to interpreting clinical trial data. This webinar is part ONE of a two-part series intended for patients, advocates, and other stakeholders who are interested in learning more about the clinical trial process for HBV and HDV. The webinar is co-hosted by the Hepatitis B Foundation and the National Viral Hepatitis Roundtable (NVHR).

Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs based on three criteria: liver disease severity (“fibrosis”), alcohol and drug use (“sobriety”), and prescriber limitations. In response to advocacy and litigation, these restrictions have been reduced or eliminated in many states, increasing access to lifesaving treatment. Yet significant barriers remain. Hepatitis C: State of Medicaid Access considers new and existing barriers to treatment access and dives deeper into the role that state Medicaid programs play in progressing towards a country free of viral hepatitis.

NVHR and Treatment Action Group (TAG) discuss what it will take to make rapid HCV diagnostics a reality in the United States. Dr. Anne Gaynor from the Association of Public Health Laboratories (APHL) walks us through the FDA announcement to reclassify HCV diagnostics.

Hear from pharmacists across the country who are providing viral hepatitis care in unique settings. During this webinar, we discuss opportunities and barriers to increasing pharmacist involvement in viral hepatitis care.

Hear from Arizona, Hawai'i, Pennsylvania, and Virginia leaders and organizers on strategies and tips for growing a statewide coalition -- getting started, recruiting partners and members, setting priorities, and keeping up engagement and momentum.

The National Viral Hepatitis Roundtable, in partnership with the Empire Liver Foundation and HepCure, hosted a webinar on prescribing buprenorphine in hepatitis care settings. In this webinar Dr. Maggie Lowenstein discusses practical ways to prescribe medication for opioid use disorder in a patient-centered manner.

Hepatitis B Foundation, Hep B United, AAPCHO, AVAC, NVHR, the National Consumers League (NCL), and The AIDS Institute co-hosted a congressional briefing regarding advancing health equity through adult hepatitis B vaccination in recognition of National Adult Hepatitis B Vaccination Awareness Day (April 30).

HepCure, National Viral Hepatitis Roundtable, and Treatment Action Group co-hosted a webinar regarding the injection drug use and health disparities among Puerto Ricans, and implications for HCV care and elimination.

The National Hepatitis Corrections Network (NHCN) and the National Viral Hepatitis Roundtable (NVHR) hosted a webinar and expert Q&A with

The National Viral Hepatitis Roundtable hosted an expert Q&A with NVHR Patient and Provider advocates about the COVID-19 vaccine.

The National Viral Hepatitis Roundtable, NASTAD, Hepatitis B Foundation, and Hep B United hosted a training for patient, provider and community advocates who are interested in meeting with their members of Congress.

Public Communications for Hepatitis Advocacy Policy advocacy relies on publicly-facing communications to inform community awareness, call attention to barriers to care, and call for leaders to take action. In this educational webinar, NVHR Advocates will learn how to shape their communications to drive progress in their communities. This webinar will dive into specific methods for...

State Viral Hepatitis Advocacy This presentation co-hosted by the National Viral Hepatitis Roundtable and the Hep B Foundation will provide viral hepatitis advocates with tangible skills and strategies to get involved in state-level viral hepatitis advocacy. Presenters will address: identifying legislative calendars, working with your Governor’s office, influencing appropriations, sharing lived experiences for advocacy, and...

340B Demystified The 340B Drug Pricing Program is a valuable tool for many providers of viral hepatitis care. We hear often from clinicians and public health programs unsure about how to best utilize the program to benefit underserved populations. On this webinar we will hear from experts in the field who will provide details about...

Defining Priorities and Strategies for Viral Hepatitis This is the first event of the NVHR Provider Advocacy Network. We will discuss viral hepatitis policy priorities as a group, and will learn about the various ways in which providers may consider engaging in advocacy in 2020.